Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000638982 | SCV000760540 | likely benign | Familial melanoma | 2024-07-15 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001816587 | SCV002068056 | uncertain significance | not specified | 2020-04-21 | criteria provided, single submitter | clinical testing | DNA sequence analysis of the CDK4 gene demonstrated a sequence change in intron 5, c.633-10C>G. This change does not appear to have been previously described in patients with CDK4-related disorders and has also not been described in population databases (gnomAD, ExAC). This sequence change is not clearly predicted to have a deleterious effect on splicing based on in silico splice prediction programs. It is possible that this sequence change represents a benign sequence change in the CDK4 gene that has not been identified to date. The functional significance of this sequence change is not known at present and its contribution to this patient's disease phenotype cannot definitively be determined. |